SNY and SAN:FP Related Headlines
Go Back- Sanofi (SAN:FP) (SNY) PT Lowered to EUR80 at Citi
- BofA Securities Downgrades Sanofi (SAN:FP) (SNY) to Neutral
- Citi Starts Sanofi (SAN:FP) (SNY) at Neutral
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR105 at Deutsche Bank
- UBS Downgrades Sanofi (SAN:FP) (SNY) to Neutral
- Barclays Downgrades Sanofi (SAN:FP) (SNY) to Equalweight
- TD Cowen Reiterates Hold Rating on Sanofi (SAN:FP) (SNY)
- Jefferies Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- Leerink Partners Reiterates Outperform Rating on Sanofi (SAN:FP) (SNY)
- JPMorgan Reiterates Neutral Rating on Sanofi (SAN:FP) (SNY)
- Jefferies Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR105 at Berenberg
- UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- Guggenheim Downgrades Sanofi (SAN:FP) (SNY) to Neutral
- JPMorgan Downgrades Sanofi (SAN:FP) (SNY) to Neutral
- Barclays Reiterates Overweight Rating on Sanofi (SAN:FP) (SNY)
- UBS Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR105 at UBS
- Deutsche Bank Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- Berenberg Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- Sanofi (SAN:FP) (SNY) PT Raised to EUR10.40 at Goldman Sachs
- Morgan Stanley Upgrades Sanofi (SAN:FP) (SNY) to Overweight
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR110 at Berenberg
- BofA Securities Reiterates Buy Rating on Sanofi (SAN:FP) (SNY)
- Deutsche Bank Upgrades Sanofi (SAN:FP) (SNY) to Buy
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR105 at Barclays
- JPMorgan Upgrades Sanofi (SAN:FP) (SNY) to Overweight
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR90 at Deutsche Bank
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR115 at Barclays
- Deutsche Bank Reiterates Hold Rating on Sanofi (SAN:FP) (SNY)
- Sanofi (SAN:FP) (SNY) PT Lowered to EUR8.40 at BofA Securities

